BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 12925213)

  • 1. Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages.
    Komatsu N; Takata M; Otsuki N; Toyama T; Ohka R; Takehara K; Saijoh K
    J Invest Dermatol; 2003 Sep; 121(3):542-9. PubMed ID: 12925213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases.
    Komatsu N; Saijoh K; Toyama T; Ohka R; Otsuki N; Hussack G; Takehara K; Diamandis EP
    Br J Dermatol; 2005 Aug; 153(2):274-81. PubMed ID: 16086736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation.
    Borgoño CA; Michael IP; Komatsu N; Jayakumar A; Kapadia R; Clayman GL; Sotiropoulou G; Diamandis EP
    J Biol Chem; 2007 Feb; 282(6):3640-52. PubMed ID: 17158887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Spink6 in mouse skin: the conserved inhibitor of kallikrein-related peptidases is reduced by barrier injury.
    Fischer J; Wu Z; Kantyka T; Sperrhacke M; Dimitrieva O; Koblyakova Y; Ahrens K; Graumann N; Baurecht H; Reiss K; Schröder JM; Proksch E; Meyer-Hoffert U
    J Invest Dermatol; 2014 May; 134(5):1305-1312. PubMed ID: 24352040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPINK5 knockdown in organotypic human skin culture as a model system for Netherton syndrome: effect of genetic inhibition of serine proteases kallikrein 5 and kallikrein 7.
    Wang S; Olt S; Schoefmann N; Stuetz A; Winiski A; Wolff-Winiski B
    Exp Dermatol; 2014 Jul; 23(7):524-6. PubMed ID: 24848304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of kallikrein-related peptidases by the serine protease inhibitor of Kazal-type 6.
    Kantyka T; Fischer J; Wu Z; Declercq W; Reiss K; Schröder JM; Meyer-Hoffert U
    Peptides; 2011 Jun; 32(6):1187-92. PubMed ID: 21439340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients.
    Komatsu N; Saijoh K; Kuk C; Liu AC; Khan S; Shirasaki F; Takehara K; Diamandis EP
    Exp Dermatol; 2007 Jun; 16(6):513-9. PubMed ID: 17518992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human tissue kallikreins as promiscuous modulators of homeostatic skin barrier functions.
    Eissa A; Diamandis EP
    Biol Chem; 2008 Jun; 389(6):669-80. PubMed ID: 18627299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy.
    Komatsu N; Saijoh K; Kuk C; Shirasaki F; Takehara K; Diamandis EP
    Br J Dermatol; 2007 May; 156(5):875-83. PubMed ID: 17459012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum.
    Ishida-Yamamoto A; Deraison C; Bonnart C; Bitoun E; Robinson R; O'Brien TJ; Wakamatsu K; Ohtsubo S; Takahashi H; Hashimoto Y; Dopping-Hepenstal PJ; McGrath JA; Iizuka H; Richard G; Hovnanian A
    J Invest Dermatol; 2005 Feb; 124(2):360-6. PubMed ID: 15675955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic processing of human growth hormone by multiple tissue kallikreins and regulation by the serine protease inhibitor Kazal-Type5 (SPINK5) protein.
    Komatsu N; Saijoh K; Otsuki N; Kishi T; Micheal IP; Obiezu CV; Borgono CA; Takehara K; Jayakumar A; Wu HK; Clayman GL; Diamandis EP
    Clin Chim Acta; 2007 Feb; 377(1-2):228-36. PubMed ID: 17140555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of SPINK6 in human skin: selective inhibitor of kallikrein-related peptidases.
    Meyer-Hoffert U; Wu Z; Kantyka T; Fischer J; Latendorf T; Hansmann B; Bartels J; He Y; Gläser R; Schröder JM
    J Biol Chem; 2010 Oct; 285(42):32174-81. PubMed ID: 20667819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dichotomous effect of ultraviolet B on the expression of corneodesmosomal enzymes in human epidermal keratinocytes.
    Nin M; Katoh N; Kokura S; Handa O; Yoshikawa T; Kishimoto S
    J Dermatol Sci; 2009 Apr; 54(1):17-24. PubMed ID: 19118981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers.
    Dong Y; Kaushal A; Brattsand M; Nicklin J; Clements JA
    Clin Cancer Res; 2003 May; 9(5):1710-20. PubMed ID: 12738725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides.
    Komatsu N; Takata M; Otsuki N; Ohka R; Amano O; Takehara K; Saijoh K
    J Invest Dermatol; 2002 Mar; 118(3):436-43. PubMed ID: 11874482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-specific promoter utilisation of the kallikrein-related peptidase genes, KLK5 and KLK7, and cellular localisation of the encoded proteins suggest roles in exocrine pancreatic function.
    Dong Y; Matigian N; Harvey TJ; Samaratunga H; Hooper JD; Clements JA
    Biol Chem; 2008 Feb; 389(2):99-109. PubMed ID: 18163887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor.
    Meyer-Hoffert U; Wu Z; Schröder JM
    PLoS One; 2009; 4(2):e4372. PubMed ID: 19190773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated kallikrein-related peptidase activity disrupts desquamation and leads to stratum corneum thickening in human skin equivalent models.
    McGovern JA; Meinert C; de Veer SJ; Hollier BG; Parker TJ; Upton Z
    Br J Dermatol; 2017 Jan; 176(1):145-158. PubMed ID: 27442805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6.
    Egelrud T; Brattsand M; Kreutzmann P; Walden M; Vitzithum K; Marx UC; Forssmann WG; Mägert HJ
    Br J Dermatol; 2005 Dec; 153(6):1200-3. PubMed ID: 16307658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPINK9: a selective, skin-specific Kazal-type serine protease inhibitor.
    Brattsand M; Stefansson K; Hubiche T; Nilsson SK; Egelrud T
    J Invest Dermatol; 2009 Jul; 129(7):1656-65. PubMed ID: 19194479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.